Evidence map›Paper›PMID 40092476›Full record

ArticleExploratory research in clinical and social pharmacy2025

The impact of simulated visual impairment on medication use process: A study with healthy volunteers.

Théodora Merenda, Fanny Depasse, Stéphanie Patris

Abstract read
In one paragraph

Article in Exploratory research in clinical and social pharmacy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Théodora MerendaUnit of Clinical Pharmacy, Faculty of Medicine, Pharmacy, and Biomedical Sciences, University of Mons (UMONS), Mons, Belgium.
Fanny DepasseUnit of Ophthalmology and Low Vision, Functional rehabilitation Centre, Association Les Amis des Aveugles (ADA), Ghlin, Belgium.
Stéphanie PatrisUnit of Clinical Pharmacy, Faculty of Medicine, Pharmacy, and Biomedical Sciences, University of Mons (UMONS), Mons, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Visual impairment may be caused by various diseases and can impact the safe use of medications. It is therefore important that healthcare professionals consider these challenges to facilitate the correct administration of medications by visually impaired patients. Objective: To determine the category of visual impairment beyond which it becomes impossible to identify medication boxes, to read patient information leaflets, expiration dates, and dosage instructions. Methods: Visual impairment was simulated with glasses on healthy volunteers who had to identify and read different elements on medication boxes and leaflets. The participant eligibility was confirmed through the administration of five ophthalmological tests designed to quantify functional vision. Data were analyzed using a within-subject repeated measures ANOVA. Results: Ninety-two simulations were conducted. This study indicates that for a simulated moderate visual impairment, 81 % of participants lacked access to the medication names and doses, 75 % lacked access to the full expiration date, and 60 % were unable to read the leaflets. Additionally, a simulated moderate visual impairment resulted in a reduced reading speed of 44 words per minute. The low contrast of the writing on medication boxes makes identification more difficult. Conclusions: This simulation study demonstrated that it became impossible to identify medication boxes from a severe visual impairment onwards, while it was no longer possible to read leaflets and expiry dates from a moderate visual impairment onwards. Consequently, it is necessary to ensure that the patient has strategies to identify medications, particularly if the packaging exhibits low contrast and small print.

Indexed as

Health careMedication safetySimulated visual impairmentSimulationVisual impairment

Identifiers

PMID40092476
PMCPMC11910069

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.